Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.56 |
| ▸ | TSHR | P16473 | 1/20 | 0.56 |
| ▸ | MAPT | P10636 | 2/20 | 0.55 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.48 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.46 |
| ▸ | GLO1 | Q04760 | 1/20 | 0.46 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.46 |
| ▸ | MGAM | O43451 | 1/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | SI | P14410 | 1/20 | 0.46 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.46 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.46 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.45 |
| ▸ | THRB | P10828 | 1/20 | 0.43 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.43 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28293945 | 1.00 | ALDH1A1 (0.56) | ALDH1A1TSHRMAPTLMNAHSD17B10 | |
| SCHEMBL28099320 | 0.97 | ALDH1A1 (0.54) | ALDH1A1TSHRMAPTLMNAHSD17B10 | |
| Ammonia Solution, Strong SCHEMBL28294025 | 0.97 | ALDH1A1 (0.54) | ALDH1A1TSHRMAPTLMNAHSD17B10 | |
| SCHEMBL13269637 | 0.94 | ALDH1A1 (0.56) | ALDH1A1TSHRMAPTLMNAHSD17B10 | |
| Acetic Acid SCHEMBL28826956 | 0.92 | ALDH1A1 (0.55) | ALDH1A1TSHRMAPTLMNAHSD17B10 | |
| Benzene SCHEMBL27784210 | 0.92 | ALDH1A1 (0.66) | ALDH1A1TSHRMAPTLMNAHSD17B10 | |
| SCHEMBL19679991 | 0.92 | THRB (0.54) | ALDH1A1TSHRMAPTLMNAHSD17B10 | |
| SCHEMBL6657389 | 0.90 | ALDH1A1 (0.48) | ALDH1A1TSHRMAPTLMNAHSD17B10 | |
| SCHEMBL14886410 | 0.88 | TSHR (0.53) | ALDH1A1TSHRMAPTLMNAHSD17B10 | |
| SCHEMBL15536700 | 0.88 | ALDH1A1 (0.47) | ALDH1A1TSHRMAPTLMNAHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1080 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12595229-B2 | Method for producing derivative of organic substance and method for analyzing sample containing organic substance | AJINOMOTO CO., INC. (JP) | 2026-04-07 | — | — | US | claimed |
| CN-119552307-A | Preparation method of ester modified SBC carbon five petroleum resin | 恒河材料科技股份有限公司 | 2025-03-04 | — | — | CN | claimed |
| US-20240374562-A1 | METHODS AND COMPOSITIONS COMPRISING A NITRITE-REDUCTASE PROMOTER FOR TREATMENT OF MEDICAL DISORDERS AND PRESERVATION OF BLOOD PRODUCTS | EPICENTRX, INC. (US) | 2024-11-14 | — | — | US | claimed |
| US-12005475-B2 | Multi-layer curable compositions containing 1,1-di-activated vinyl compound products and related processes | PPG INDUSTRIES OHIO, INC. (US) | 2024-06-11 | — | — | US | claimed |
| US-11999866-B2 | Polymalonate and cyanoacrylate based surface concrete sealers | ZEPHYROS, INC. (US) | 2024-06-04 | — | — | US | claimed |
| EP-3515994-B1 | METHOD FOR SEALING POROUS SUBSTRATES | ZEPHYROS INC (US) | 2024-01-24 | — | — | EP | claimed |
| CN-114127220-B | Curable composition useful for obtaining a non-sensitized cured product | 阿科玛法国公司 | 2024-01-19 | — | — | CN | claimed |
| US-11859101-B2 | Curable compositions containing 1,1-di-activated vinyl compounds and related coatings and processes | PPG INDUSTRIES OHIO, INC. (US) | 2024-01-02 | — | — | US | claimed |
| CN-115181277-B | Preparation method of metal composite polymer single-chain nano particles | 中国科学院化学研究所 | 2023-12-01 | — | — | CN | claimed |
| EP-3490724-B1 | POLYURETHANE COATING COMPOSITIONS CONTAINING 1,1-DI-ACTIVATED VINYL COMPOUNDS AND RELATED COATINGS AND PROCESSES | PPG IND OHIO INC (US) | 2023-09-20 | — | — | EP | claimed |
| US-20080096805-A1 | deoxygenated, endotoxin-free and stroma-free transport proteins, incapable of binding with nitric oxide, useful as substitutes for erythrocytes in mammals and for treating disorders where oxygen delivery agents are of benefit | IKOR, INC. | 2008-04-24 | — | — | US | claimed |
| CN-101106968-A | 2 -C-substituted propane-1, 3 -dicarbonyl compounds and their use in neutralising malodour | GIVAUDAN SA (CH) | 2008-01-16 | — | — | CN | claimed |
| US-20060085922-A1 | Oxidizing composition comprising at least one electrophilic monomer and at least one non-benzoquinone oxidant | L'OREAL S.A. (FR) | 2006-04-27 | — | — | US | claimed |
| EP-1542704-A1 | METHOD AND COMPOSITION FOR PREVENTING PAIN IN SICKLE CELL PATIENTS | Embury, Stephen H. (US) | 2005-06-22 | — | — | EP | claimed |
| US-20040072796-A1 | Method and composition for preventing pain in sickle cell patients | TRF PHARMA, INC. | 2004-04-15 | — | — | US | claimed |
| CN-1132818-C | 4-oxo-1, 4-dihydro-3-quinolinecarboxamides as antiviral agents | PHARMACIA & UPJOHN CO. (US) | 2003-12-31 | — | — | CN | claimed |
| WO-2003088980-A1 | METHOD AND COMPOSITION FOR PREVENTING PAIN IN SICKLE CELL PATIENTS | EMBURY STEPHEN H (US) | 2003-10-30 | — | — | WO | claimed |
| CN-1332729-A | 4-oxo-1,4-dihybro-3-quinolinecarboxamides as antiviral agents | PHARMACIA & UP JOHN CO (US) | 2002-01-23 | — | — | CN | claimed |
| EP-0376870-A1 | A new organosilylpolyphosphoric reagent, its preparation and application to the process of synthesis of 3-carboxyquinolones or azaquinolones and their salts | CENTRO MARGA PARA LA INVESTIGACION S.A. (ES) | 1990-07-04 | — | — | EP | claimed |
| EP-0102404-A1 | Novel polycyclic fused pyrazole compounds useful as antiinflammatory agents and preparation thereof | STERLING DRUG INC. (US) | 1984-03-14 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060085922-A1 | Oxidizing composition comprising at least one electrophilic monomer and at least one non-benzoquinone oxidant | KRT18, GPX4, NOX4 | ALDH1A1 303/4885TSHR 4243/4885MAPT 2098/4885 |
| US-12595229-B2 | Method for producing derivative of organic substance and method for analyzing sample containing organic substance | SULT1E1, CNR2, SRMS | ALDH1A1 672/4885TSHR 2375/4885MAPT 4797/4885 |
| US-20240374562-A1 | METHODS AND COMPOSITIONS COMPRISING A NITRITE-REDUCTASE PROMOTER FOR TREATMENT OF MEDICAL DISORDERS AND PRESERVATION OF BLOOD PRODUCTS | HBB, HBG2, HBZ | ALDH1A1 1464/4885TSHR 799/4885MAPT 4665/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.